Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
algorithm
aortic wall, thickened
arteritis, temporal
arteritis, temporal, recurrent
basilar artery stenosis
bursitis
carotid artery, enlarged external diameter
CAT scan, angiography
CAT scan, emission, abnormal
cerebellar infarction
cerebral arteries
cerebrovascular accident
complications
C-reactive protein, elevated
diagnostic criteria
efficacy
giant cell arteritis
halo sign
imbalance
interleukin 6
Janus kinase inhibitors
monoclonal antibodies
MRI, abnormal
MRI, angiography
MRI, contrast enhanced
MRI, vessel wall
muscle stiffness
neurologic disease, diagnoses of
new onset refractory status epilepticus
overlap syndrome
pain
pain, arm
polymyalgia rheumatica
posterior circulation stroke
recurrent
review article
safety
sarilumab
sedimentation rate
sedimentation rate, elevated
seizure, intractable
seizure, treatment of
shoulder, pain in
status epilepticus
status epilepticus, intractable
steroid sparing therapy
steroid therapy, CNS treatment and complications with
stiff joints
temporal artery, biopsy
tocilizumab
treatment of neurologic disorder
ultrasonography
ultrasonography, carotid artery
upadacitinib
vasculopathy
vertebral artery
vertebral artery disease
vertebral artery occlusion
vertebral-basilar insufficiency
vertebrobasilar artery thickening
vertebrobasilar, artery stenosis
Showing articles 750 to 800 of 1125 << Previous Next >>

Vascular Effects of Statins in Stroke
Stroke 28:2315-2320, Delanty,N.&Vaughan,C.J., 1997

An Update on Primary Drug Therapies for Alzheimer Disease
Arch Neurol 54:1406-1409, Knopman,D.S.&Morris,J.C., 1997

Clinical Experience with Donepezil Hydrochloride:A Case Study Perspective
Advan Therapy 14:305-311, Geldmacher,D.S., 1997

Cerebrospinal Fluid Creatine Kinase BB Isoenzyme Activity & Neurol Prog after Cardiac Arrest
Neurol 48:352-357, Tirschwell,D.L.,et al, 1997

Drug Treatment of Alzheimer's Disease, Raise Clinical and Ethical Problems
BMJ 314:693-694, Kelley,C.A.,et al, 1997

HIV-1 Protease Inhibitors
JAMA 227:145-149, Deeks,S.J.,et al, 1997

Evaluation of Neuromuscular Symptoms in Veterans of the Persian Gulf War
Neurol 48:4-12, Amato,A.A.,et al, 1997

Self-Reported Exposure to Neurotoxic Chemical Combinations in the Gulf War:A Cross-Sectional Epidemiologic Study
JAMA 227:231-237, 2591997., Haley,R.W.&Kurt,T.L., 1997

Muscle-Eye-Brain Disease:A Neuropathological Study
Ann Neurol 41:173-180, Haltia,M.,et al, 1997

Remission of PML Following Splenectomy & Antiretroviral Therapy in a Pt with HIV Infection
NEJM 336:661-662, Power,C.,et al, 1997

HIV Infection-1
BMJ 314:487-491, 579-5831997., Cohn,J.A., 1997

Gluteal Compartment Syndrome Due to Rhabdomyolysis After Heroin Abuse
Neurol 48:275-276, Klockgether,T.,et al, 1997

Antidepressants and Chronic Pain
BMJ 314:763-764, McQuay,H.J.&Moore,R.A., 1997

2-5 Yr Remission of AIDS-Assoc Progressive Multifocal Leukoencephalopathy with Combined Antiretroviral Therapy
Lancet 349:850, Elliot,B.,et al, 1997

Severe Pathological Crying After Left Anterior Choroidal Artery Infarct
Stroke 28:1464-1466, Derex,L.,et al, 1997

Influence of Cholesterol on Survival After Stroke:Retrospective Study
BMJ 314:1584-1588, Dyker,A.G.,et al, 1997

Donepezil (Aricept) for Alzheimer's Disease
The Medical Letter 39:53-54, , 1997

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
NEJM 336:1216-1222, 12451997., Sano,M.,et al, 1997

Antioxidants and Dementia
Lancet 349:1189-1190, Lethem,R.&Orrell,M., 1997

Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997

A 9-Year-Old With Fever and Severe Muscle Pains
Lancet 349:1666, Punda-Polic,V.,et al, 1997

Treatment of Acquired Myasthenia Gravis
Neurol 48 (Suppl 5) :S46-S51997., Massey,J.M., 1997

Dietary Antioxidants and Parkinson Disease
Arch Neurol 54:762-765, deRijk,M.C.,et al, 1997

Tolcapone in Stable Parkinson's Disease:Efficacy and Safety of Long-Term Treatment
Neurol 49:665-671, Waters,C.H.,et al, 1997

Serotonin Syndrome and the Combined Use of Deprenyl and An Antidepressant in Parkinson's Disease
Neurol 48:1070-1077, Richard,I.H.,et al, 1997

Acute Corticosteroid Myopathy in Intensive Care Patients
Muscle & Nerve 20:1371-1380997., Hanson,P.,et al, 1997

Extrapyramidal Side Effects with Low-Dose Risperidone
Can J Psychiatry 42:325-325, Brown, E.S., 1997

Neurologic ad Psychiatric Symptoms of Legionella Infection. Case Report and overview of the Clinical Spectrum
Nervenarzt 68:342-345, Plaschke,M.,et al, 1997

Movement Disorders Associated with the Serotonin Selective Reuptake Inhibitors
J Clin Psychiatry 57:449-454, Leo,R.J., 1996

Clozapine-Induced Myotoxicity in Patients with Chronic Psychotic Disorders
Neurol 47:1518-1523, Scelsa,S.N.,et al, 1996

Isolated Vitamin E Deficiency
Muscle & Nerve 19:1161-1165996., Jackson,C.E.,et al, 1996

Pravastatin Reduces Carotid Intima-Media Thickness Prog in an Asympt Hypercholesterolemic Pop, CAIUS Study
Am J Med 101:627-634, Mercuri,M.,et al, 1996

Reduction in Carotid Arterial Wall Thickness Using Lovastatin & Dietary Therapy
Ann Int Med 124:548-556, Hodis,H.N.,et al, 1996

Familial Migraine with Vertigo and Essential Tremor
Neurol 46:458-460, Baloh,R.W.,et al, 1996

Cognitive Dysfunction as the Major Presenting Feature of Becker's Muscular Dystrophy
Neurol 46:461-465, North,K.N.,et al, 1996

Clinical Heterogeneity of Adhalin Deficiency
Ann Neurol 39:196-202, Morandi,L.,et al, 1996

Cognitive Impairment & Mortality in a Cohort of Elderly People
BMJ 312:608-611, Gale,C.R.,et al, 1996

Dietary Flavonoids, Antioxidant Vitamins, and Incidence of Stroke
Arch Int Med 154:637-642, Keli,S.O.,et al, 1996

A Controlled Trial of Deprenyl in Children with Tourette's Syndrome and Attention Deficit Hyperactivity Disorder
Neurol 46:965-968, Feigin,A.,et al, 1996

Long-Term Tacrine (Cognex) Treatment:Effects on Nursing Home Placement and Mortality
Neurol 47:166-177, Knopman,D.,et al, 1996

Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Subjects Not Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:29-361996., , 1996

Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Patients Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:37-451996., , 1996

Congenital Muscular Dystrophy Syndromes Distinguished by Alkaline and Acid Phosphatase, Merosin, & Dystrophin Staining
Neurol 46:810-814, Connolly,A.M.,et al, 1996

Investigation of Muscle Disease
JNNP 60:256-274, Mastaglia,F.L.&Laing,N.G., 1996

Coexistence of Migraine and Idiopathic Intracranial Hypertension without Papilledema
Neurol 46:1226-1230, Mathew,N.T.,et al, 1996

Case-Control Study of Idiopathic Parkinson's Disease and Dietary Vitamin E Intake
Neurol 46:1270-1274, Morens,D.M.,et al, 1996

Multifocal Motor Neuropathy
JNNP 60:599-603, Nobile-Orazio,E., 1996

Effects of Fluoxetine and Maprotiline on Functional Recovery in Poststroke Hemiplegic Pts Undergoing Rehab Therapy
Stroke 27:1211-1214, Dam,M.,et al, 1996

Selegiline and Mortality in Parkinson's Disease
Ann Neurol 40:841-845, Olanow,C.W.,et al, 1996

A Depressed Workman with Heatstroke
Lancet 347:1016, Albukrek,D.,et al, 1996



Showing articles 750 to 800 of 1125 << Previous Next >>